bulk drug market

Global Bulk Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

  • Published Date: 2021-01-25
  • Report ID: 44300
  • Pages: 129
  • Format: prudent report format

Summary

World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.

Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.

Prudent Marketss analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

This research report indicated that the global Bulk Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Bulk Drug Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Bulk Drug Market
Teva
Novartis
Pfizer
Johnson and Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddys Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
...
Major Type of Bulk Drug Covered in Prudent Markets report:
Vitamin
Antibiotic
Iohexol
Hormone
Amino Acid
Application Segments Covered in Prudent Markets Market
Orthopedics Disease
Others

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

Global Bulk Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Vitamin -Product Introduction and Major Manufacturers
1.1.2 Antibiotic -Product Introduction and Major Manufacturers
1.1.3 Iohexol -Product Introduction and Major Manufacturers
1.1.4 Hormone -Product Introduction and Major Manufacturers
1.1.5 Amino Acid -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Bulk Drug Status and Prospect (2015-2026)
2.1.1 China Bulk Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Bulk Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Bulk Drug Status and Prospect (2015-2026)
2.2.1 EU Bulk Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Bulk Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Bulk Drug Status and Prospect (2015-2026)
2.3.1 USA Bulk Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Bulk Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Bulk Drug Status and Prospect (2015-2026)
2.4.1 Japan Bulk Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Bulk Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Bulk Drug Status and Prospect (2015-2026)
2.5.1 India Bulk Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Bulk Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Bulk Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Bulk Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Bulk Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Bulk Drug Status and Prospect (2015-2026)
2.7.1 South America Bulk Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Bulk Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Bulk Drug Status and Prospect (2015-2026)
2.8.1 Bulk Drug Market Size and Growth Rate (2015-2026)
2.8.2 Bulk Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Bulk Drug Market Assessment by Segment
3.1 Global Bulk Drug Capacity and Growth Rate
3.2 Global Bulk Drug Sales by Type
3.3 Global Bulk Drug Sales Revenue by Type
3.4 Global Bulk Drug Consumption by Application
4 Global Bulk Drug Market Assessment by Regions
4.1 Global Bulk Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Bulk Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Bulk Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Bulk Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Bulk Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Bulk Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Bulk Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Bulk Drug Sales Revenue Market Share of Manufacturers (2019-2020)

7 Bulk Drug Competitive Analysis
7.1 Teva
7.1.1 Teva Company Profiles
7.1.2 Teva Product Introduction
7.1.3 Teva Bulk Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Novartis
7.2.1 Novartis Company Profiles
7.2.2 Novartis Product Introduction
7.2.3 Novartis Bulk Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Pfizer
7.3.1 Pfizer Company Profiles
7.3.2 Pfizer Product Introduction
7.3.3 Pfizer Bulk Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Johnson and Johnson
7.4.1 Johnson and Johnson Company Profiles
7.4.2 Johnson and Johnson Product Introduction
7.4.3 Johnson and Johnson Bulk Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Mylan
7.5.1 Mylan Company Profiles
7.5.2 Mylan Product Introduction
7.5.3 Mylan Bulk Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 North China Pharmaceutical Group
7.6.1 North China Pharmaceutical Group Company Profiles
7.6.2 North China Pharmaceutical Group Product Introduction
7.6.3 North China Pharmaceutical Group Bulk Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Dr. Reddys Laboratories
7.7.1 Dr. Reddys Laboratories Company Profiles
7.7.2 Dr. Reddys Laboratories Product Introduction
7.7.3 Dr. Reddys Laboratories Bulk Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Roche
7.8.1 Roche Company Profiles
7.8.2 Roche Product Introduction
7.8.3 Roche Bulk Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Aurobindo pharma
7.9.1 Aurobindo pharma Company Profiles
7.9.2 Aurobindo pharma Product Introduction
7.9.3 Aurobindo pharma Bulk Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Sun Pharmaceutical Industries
7.10.1 Sun Pharmaceutical Industries Company Profiles
7.10.2 Sun Pharmaceutical Industries Product Introduction
7.10.3 Sun Pharmaceutical Industries Bulk Drug Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Boehringer Ingelheim GmbH
7.12 Bayer
7.13 BASF
7.14 DSM
7.15 Zhejiang Medicine
7.16 Biocon
7.17 Johnson Matthey
7.18 Hisun Pharmacy
7.19 Cambrex
7.20 Shandong Xinhua Pharmaceutical
7.21 Lonza group
7.22 Huahai Pharmaceutical
7.23 Haerbin Pharmaceutical Group
8 Conclusion


CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.